blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4346621

EP4346621 - COMBINED BIOLOGICAL SAMPLING AND INJECTION ASSEMBLIES AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.03.2024
Database last updated on 24.07.2024
FormerThe international publication has been made
Status updated on  02.12.2022
Formerunknown
Status updated on  21.06.2022
Most recent event   Tooltip01.07.2024New entry: Additional fee for renewal fee: despatch of communication + time limit 
Applicant(s)For all designated states
Twenty Twenty Therapeutics LLC
259 East Grand Avenue
South San Francisco, CA 94080 / US
[2024/15]
Inventor(s)01 / TUMLINSON, Alexandre R.
South San Francisco, California 94080 / US
02 / KAPLAN, Ellen
South San Francisco, California 94080 / US
 [2024/15]
Representative(s)Potter Clarkson
Chapel Quarter
Mount Street
Nottingham NG1 6HQ / GB
[2024/15]
Application number, filing date22730007.623.05.2022
[2024/15]
WO2022US30472
Priority number, dateUS202163192480P24.05.2021         Original published format: US 202163192480 P
[2024/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022251089
Date:01.12.2022
Language:EN
[2022/48]
Type: A1 Application with search report 
No.:EP4346621
Date:10.04.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 01.12.2022 takes the place of the publication of the European patent application.
[2024/15]
Search report(s)International search report - published on:EP01.12.2022
ClassificationIPC:A61B10/00, A61B10/02, A61M5/34, A61F9/00, B65D51/00
[2024/15]
CPC:
A61B10/0045 (EP,KR); A61B10/0283 (EP,KR); A61J1/2096 (US);
A61B10/0096 (EP,KR); A61F9/0008 (EP,KR); A61J1/1406 (US);
A61J1/201 (US); A61J1/2055 (US); A61M5/3146 (EP,KR);
A61M5/345 (EP,KR); A61M2205/582 (EP,KR); A61M5/3202 (EP);
A61M5/3204 (EP); B65D51/002 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/15]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:KOMBINIERTE BIOLOGISCHE PROBENAHME- UND INJEKTIONSANORDNUNGEN SOWIE ZUGEHÖRIGE VORRICHTUNGEN, SYSTEME UND VERFAHREN[2024/15]
English:COMBINED BIOLOGICAL SAMPLING AND INJECTION ASSEMBLIES AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS[2024/15]
French:ENSEMBLES D'ÉCHANTILLONNAGE ET D'INJECTION BIOLOGIQUES COMBINÉS ET DISPOSITIFS, SYSTÈMES ET PROCÉDÉS ASSOCIÉS[2024/15]
Entry into regional phase06.12.2023National basic fee paid 
06.12.2023Designation fee(s) paid 
06.12.2023Examination fee paid 
Examination procedure06.12.2023Amendment by applicant (claims and/or description)
06.12.2023Examination requested  [2024/15]
06.12.2023Date on which the examining division has become responsible
Fees paidRenewal fee
17.06.2024Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.05.202403   M06   Fee paid on   17.06.2024
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]US5033476  (KASAI MASAAKI [JP]) [X] 1,5 * column 7, line 50 - column 10, line 1; figures 2, 4-6 * [Y] 2,3 [I] 4;
 [XYI]EP1174085  (BECTON DICKINSON CO [US]) [X] 1,4 * paragraph [0001] * * paragraph [0014] - paragraph [0021]; figures 3-6 * [Y] 2,3 [I] 5;
 [XAI]US2012191008  (LI RONSHANG [US]) [X] 16,19 * paragraph [0060] * * paragraph [0077] - paragraph [0083]; figures 1, 15-17 * * paragraph [0104] - paragraph [0106] * [A] 1-15 [I] 17,18;
 [A]US2014213934  (ELLIS ROBERT G [US], et al) [A] 1 * paragraph [0056]; figures 7, 10 *;
 [A]WO2017184084  (SINGAPORE HEALTH SERV PTE LTD [SG]) [A] 6-15 * the whole document *;
 [YA]US9883968  (DOUD DARREN [US], et al) [Y] 2,3 * column 29, line 34 - column 30, line 41; figures 1-37 * [A] 6-21;
 [XA]GB2570722  (OWEN MUMFORD LTD [GB]) [X] 16,19-21 * page 6 - page 8 * * page 12; figures 1-5 * [A] 1-15;
 [A]US2020337897  (SACHERMAN KEVIN W [US], et al) [A] 1-21 * paragraph [0139] - paragraph [0142]; figures 1-27 *;
 [X]WO2020237049  (UNIV MICHIGAN REGENTS [US], et al) [X] 16,18* paragraph [0048] - paragraph [0076]; figures 9-17 *
by applicant   - SAXENA, S.LAI, T.Y.KOIZUMI, H. et al., "Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects", International Journal of Retina and Vitreous, (20190000), vol. 5, page 8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.